GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Definitive Healthcare Corp (NAS:DH) » Definitions » EV-to-Revenue

Definitive Healthcare (Definitive Healthcare) EV-to-Revenue : 2.38 (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Definitive Healthcare EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Definitive Healthcare's enterprise value is $609.2 Mil. Definitive Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $255.7 Mil. Therefore, Definitive Healthcare's EV-to-Revenue for today is 2.38.

The historical rank and industry rank for Definitive Healthcare's EV-to-Revenue or its related term are showing as below:

DH' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.63   Med: 7.87   Max: 33.53
Current: 2.38

During the past 5 years, the highest EV-to-Revenue of Definitive Healthcare was 33.53. The lowest was 3.63. And the median was 7.87.

DH's EV-to-Revenue is ranked worse than
58.61% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 1.88 vs DH: 2.38

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-14), Definitive Healthcare's stock price is $5.45. Definitive Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $2.22. Therefore, Definitive Healthcare's PS Ratio for today is 2.45.


Definitive Healthcare EV-to-Revenue Historical Data

The historical data trend for Definitive Healthcare's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Definitive Healthcare EV-to-Revenue Chart

Definitive Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - 19.04 7.33 5.79

Definitive Healthcare Quarterly Data
Jul19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.69 6.77 5.01 5.79 4.90

Competitive Comparison of Definitive Healthcare's EV-to-Revenue

For the Health Information Services subindustry, Definitive Healthcare's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Definitive Healthcare's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's EV-to-Revenue falls into.



Definitive Healthcare EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Definitive Healthcare's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=609.231/255.694
=2.38

Definitive Healthcare's current Enterprise Value is $609.2 Mil.
Definitive Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $255.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Definitive Healthcare  (NAS:DH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Definitive Healthcare's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=5.45/2.222
=2.45

Definitive Healthcare's share price for today is $5.45.
Definitive Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Definitive Healthcare EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Definitive Healthcare's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Definitive Healthcare (Definitive Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701
Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States.
Executives
Carrie Lazorchak officer: Chief Revenue Officer C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM MA 01701
Scott G Stephenson director C/O VERISK ANALYTICS, INC., 545 WASHINGTON BOULEVARD, JERSEY CITY NJ 07310-1686
Sea Vii Management, Llc director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent International Gp, Llc director, 10 percent owner 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199
Spectrum Vii Investment Managers' Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, 35TH FLOOR, BOSTON MA 02110
Jason Ronald Krantz director, 10 percent owner, officer: Chief Executive Officer C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Jonathan Maack officer: President C/O DEFINITIVE HEALTHCARE CORP., 550 COCHITUATE RD, FRAMINGHAM MA 01701
Sastry Chilukuri director 5 BUDDY LANE, MORRISTOWN NJ 07960
David Randall Winn director 7900 GLADES ROAD, SUITE 540, BOCA RATON FL 33434
Jeffrey Charles Haywood director, 10 percent owner C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Richard Douglas Booth officer: Chief Financial Officer 200 CLARENDON STREET, T-9, BOSTON MA 02116
Kathleen A Winters director 101 COLUMBIA ROAD, MORRISTOWN NJ 07960
Spectrum Vii Co-investment Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent Global Technology-c Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069
Advent Global Technology-d Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069